Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Europäer zahlen zu viel für Pillen

18 July 2017

Open

“É possível fazer os médicos portugueses prescreverem mais genéricos”

18 July 2017

Open

Jacek Glinka: “Biossimilares podem poupar ao SNS 120 milhões de euros”

18 July 2017

Open

Pharma expert: EU drug agency should be ‘easily’ accessible to all

18 July 2017

Open

Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health

16 June 2017

Biosimilar medicines are transforming treatment by enabling better access to […]

Read more

Over 100 Participants Explore Opportunities to Ensure Universal Access to Health

27 April 2017

Over 100 participants explored different ways and opportunities to ensure […]

Read more

22nd EAHP Conference in Cannes

25 March 2017

A special satellite  symposium was organized on “Value added medicines […]

Read more

Access to Medicines at Sustainable Price: Pharma Industry and Governments Transforming Challenges into Opportunities

23 March 2017

Open

Stimulating Investment in European Generic, Biosimilar and Value Added Medicines through a Transparent Legal Environment

22 March 2017

Key authorities, eminent lawyers and industry leaders discussed today in […]

Read more

European Parliament Recognises the Major role of Generic, Biosimilar and Value Added Medicines in Improving Access

2 March 2017

Today, the European Parliament voted on the report on ‘Options […]

Read more

Subscribe to our newsletter